Fette sets up Goa tablet testing unit

By Gareth Macdonald

- Last updated on GMT

Related tags: Manufacturing

German machine tool maker Fette Compacting has set up a tablet compression and flowability testing centre in Goa, India.

The unit, which cost €600,000 to set up according to the Machinist.in​ website, houses laboratories for small-scale compression trials, sample production, materials analysis as well as capabilities for proof of concept tablet studies.

Fette’s Indian subsidiary, Fette Compacting Machinery India (FCI), will manage operations which will also include a training centre at which pharma customers can gain hands on experience of the latest tabletting platforms.

FCI MD Venkata Subramanian told India’s Business Standard that: “The centre is basically to support our clients in India, both the domestic and multi national pharma companies which have manufacturing facilities in India​.”

Subramanian also predicted that the Goa unit will generate business for the wider Fette group, particularly in terms of technology sales.

He told The Hindu newspaper that: “FCI will enable the manufacturers to fit into the production line by installing the tool and pressing machines, which are either being imported from Germany or sourced locally​.”

FCI has installed 80 tabletting machines in pharmaceutical production facilities across Indian and claims both local majors like Lupin and Dr Reddy’s and global players like GSK, Sanofi Aventis and Ranbaxy as customers.

With the new centre up and running FCI is aiming to sell between 35 and 40 more this year and generate revenues of €14m.

The Goa competence centre is the fourth that Fette has established outside Germany and is the third in Asia, behind the unit it recently opened in Singapore and the facility it set up in Nanjing, China in 2004.

Related news

Show more

Related products

show more

Liver Disease Capabilities

Liver Disease Capabilities

Q² Solutions | 01-Oct-2020 | Clinical Study

We integrate therapeutic insights, state-of-the-art technologies, best-in-class methods and quality systems to optimize NAFLD & NASH study design,...

CAR-T Cell Therapy

CAR-T Cell Therapy

Q² Solutions | 01-Sep-2020 | Clinical Study

Cell therapy involves the transfer of genetically altered cells into a patient. As a global central laboratory services organization, we provide testing...

Laboratory Solutions for COVID-19 Clinical Trials

Laboratory Solutions for COVID-19 Clinical Trials

Q² Solutions | 10-Jun-2020 | Clinical Study

As a leading laboratory services organization for trials across the globe, we are proud to partner with clients to support COVID-19 clinical trials. Our...

Related suppliers

Follow us

Products

View more

Webinars